Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript November 13, 2023

Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.15.

Ted Jenkins: Thank you, operator, and thank you all for participating in today’s conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the third quarter of 2023. Our press release is available on the Investor page of the Spero Therapeutics...